ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

July 31, 2027

Conditions
Metastatic Breast Cancer
Interventions
DRUG

Elacestrant

Starting dose 400 mg elacestrant dihydrochloride administered orally once daily for an estimated 6 months of treatment.

Trial Locations (34)

179

Cancer Research Centre, Tbilisi

Innova Medical Center, Tbilisi

LTD Simon Khechinashvili University Clinic, Tbilisi

186

Multiprofile Clinic Consilium Medulla, Tbilisi

4000

Complex Oncology Center, Plovdiv

4515

Unidad Médica Onco-Hematológica, Puebla City

4980

Fucam, Ac., Mexico City

5000

COC Veliko Tarnovo, Veliko Tarnovo

9700

COMPLEX ONCOLOGICAL CENTER - Shumen, Shumen

33756

Morton Plant Hospital - Baycare Health System, Clearwater

43606

The Toledo Clinic, Toledo

46804

Inventa Center for Cancer Research at Fort Wayne Medical Oncology and Hematology, Fort Wayne

60611

Northwestern University, Northwestern Feinberg School of Medicine Prentice Women's Hospital, Chicago

64710

I CAN Oncology Center, Centro Medico AVE, Monterrey

66204

Alliance for Multispecialty Research, Merriam

72762

Highlands Oncology Group, PA, Springdale

78229

UT Health San Antonio Mays Cancer Center, San Antonio

80045

University of Colorado Cancer Center, Aurora

89128

Comprehensive Cancer Centers of Nevada, Las Vegas

90035

Hospital de Clinicas de Porto Alegre, Porto Alegre

91007

OPN Healthcare, Arcadia

98405

Quality Cancer Care Alliance (QCCA) Northwest Medical Specialties, Tacoma

200542

"Centrul de Oncologie Sf. Nectarie", Craiova

400150

"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca", Cluj-Napoca

29308-014

Centro de Pesquisas Clinicas em Oncologia (Center for Clinical Research in Oncology (CPCO)) - Hospital Evangélico de Cachoeiro de Itapemirim, Cachoeiro de Itapemirim

70200-730

Hospital São Lucas PUCRS - Centro de Pesquisa em Oncologia (CPO), Porto Alegre

Centro De Pesquisa Clinica DO Hospital Sirio-Libanes - UNIDADE Brasilia, Brasília

88034-000

Centro de Pesquisas Oncologicas, Florianópolis

14784-400

Hospital de Amor de Barretos, Barretos

09060-650

Centro de Estudos e Pesquisas de Hematologia e Oncologia- CEPHO, Santo André

01317-001

Clinica de Pesquisas e Centro de Estudos Em Oncologia Ginecologica e Mamaria Ltda, São Paulo

Unknown

Institute of Clinical Oncology, Tbilisi

Todua Clinic, Tbilisi

06760

Torre Medica Hospital Dalinde, Mexico City

All Listed Sponsors
lead

Stemline Therapeutics, Inc.

INDUSTRY